ADVM - Adverum Biotechnologies - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ADVM is currently covered by 5 analysts with an average price target of $-4.13. This is a potential upside of $-7.62 (-218.34%) from yesterday's end of day stock price of $3.49.

Adverum Biotechnologies's activity chart (see below) currently has 22 price targets and 47 ratings on display. The stock rating distribution of ADVM is 77.78% BUY and 22.22% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 70.46% with an average time for these price targets to be met of 398.08 days.

Highest price target for ADVM is $33, Lowest price target is $5, average price target is $18.

Most recent stock forecast was given by DANIIL GATAULIN from CHARDAN CAPITAL on 17-Apr-2025. First documented stock forecast 16-Jun-2015.

Currently out of the existing stock ratings of ADVM, 14 are a BUY (77.78%), 4 are a HOLD (22.22%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$33

$29.51 (845.56%)

$40

17 days ago
(17-Apr-2025)

3/6 (50%)

$30.07 (1026.28%)

884

Hold

$5

$1.51 (43.27%)

$10

18 days ago
(16-Apr-2025)

1/4 (25%)

$2.02 (67.79%)

81

Buy

$30

$26.51 (759.60%)

$30

18 days ago
(16-Apr-2025)

0/5 (0%)

$27.02 (906.71%)

Buy

$16

$12.51 (358.45%)

$20

5 months 12 days ago
(22-Nov-2024)

1/3 (33.33%)

$9.96 (164.90%)

292

Buy

$6

$4.05 (207.69%)

$4

1 years 7 months 29 days ago
(05-Sep-2023)

4/7 (57.14%)

$4.22 (237.08%)

196

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ADVM (Adverum Biotechnologies) average time for price targets to be met?

On average it took 398.08 days on average for the stock forecasts to be realized with a an average price target met ratio 70.46

Which analyst has the current highest performing score on ADVM (Adverum Biotechnologies) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on ADVM (Adverum Biotechnologies)?

Charles Duncan works at CANTOR FITZGERALD and has 12 price targets and 8 ratings on ADVM

Which analyst is the currently most bullish on ADVM (Adverum Biotechnologies)?

Biren Amin with highest potential upside - $47.51

Which analyst is the currently most reserved on ADVM (Adverum Biotechnologies)?

Tyler Van Buren with lowest potential downside - -$0

Adverum Biotechnologies in the News

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 32,620 shares of common stock and restricted stock units (RSUs) for 16,310 shares of common stock to seven new employees...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?